DaVita Inc. (DVA) — Analysis Summary
DaVita Inc. (DVA) has a market cap of $12.08B with year-over-year revenue growth of +6.5%. Net margin stands at 5.5%. The stock trades at a P/E ratio of 14.3.
Key Takeaways
- Revenue changed +6.5% year-over-year
- Net margin of 5.5%
- P/E ratio of 14.3
Compared to other companies in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector, DVA posted revenue growth of +6.5% and trades at a P/E of 14.3.
DaVita Inc. (DVA)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
D/E at 10.0x — extreme leverage
Operating margin (15.2%) exceeds gross margin (0.0%) — check for other operating income or data classification issues
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Sector
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Employees
78,000
Headquarters
DENVER, CO
Exchange
XNYS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.